References
- 1
Czeizel A E, Intödy Z S, Modell B.
What proportion of congenital abnormalities can be prevented?.
BMJ.
1993;
306
499-503.
- 2
Smithells R W, Sheppard S, Wild J, Schorah C J.
Prevention of neural tube defect recurrences in Yorkshire: final report.
Lancet.
1989;
ii (8661)
498-499.
- 3
Nevin N C, Seller M J.
Prevention of neural-tube-defect recurrences.
Lancet.
1990;
335
178-179.
- 4 MCR Vitamin Study Research Group. Prevention of neural tube defects: results of
the Medical Research Council Vitamin Study. Lancet 1991 338: 131-137.
- 5
Czeizel A E.
Ten years of experience in periconceptional care.
Eur J Obstet Gynecol Reprod Biol.
1999;
84
43-49.
- 6
Czeizel A E, Dudás I.
Prevention of the first occurrence of neural-tube defects by periconceptional vitamin
supplementation.
N Engl J Med.
1992;
327
1832-1835.
- 7
Czeizel A E.
Prevention of congenital abnormalities by periconceptional multivitamin supplementation.
BMJ.
1993;
306
1645-1648.
- 8
Czeizel A E.
Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin
supplementation.
Am J Med Genet.
1996;
62
179-183.
- 9
Czeizel A E, Dobo M, Vargha P.
Hungarian cohort controlled trial of periconceptional multivitamin supplementation
shows reduction in certain congenital abnormalities.
Birth Defects Res A Clin Mol Teratol.
2004;
70
853-861.
- 10
Botto L D, Olney R S, Erickson J D.
Vitamin supplements and the risk for congenital anomalies other than neural tube defects.
Am J Med Genet C Semin Med Genet.
2004;
125
12-21.
- 11
Czeizel A E, Timár I, Sárközi A.
Dose-dependent effect of folic acid on the prevention of orofacial clefts.
Pediatrics.
1999;
104
e66.
- 12 Taruscio D. (Ed.) .Folic Acid: from Research to Public Health Practice. Rapporti
ISTISAN Roma; 2004: 26.
1 Summary of a lecture held at the 9th symposium of Gesellschaft für angewandte Vitaminforschung
e.V. - GVF. Bonn, 28.06.2006.
Prof. Andrew E. Czeizel
Scientific Director of the Foundation for the Community Control of Hereditary Diseases
Budapest, Hungary
